Fasting plasma levels of nesfatin-1 in patients with type 1 and type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans

Regulatory Peptides

Volumn 159, Issue 1-3, 2010, Pages 72-77

  Li, Qing Chun ^a   Wang, Hai Yan ^b   Chen, Xi ^a   Guan, Hong Zai ^a   Jiang, Zheng Yao ^a  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^b QINGDAO UNIVERSITY   (China)

Author keywords

Diabetes mellitus; Insulin; Nesfatin 1; Oral glucose ingestion

Indexed keywords

GLUCOSE; INSULIN; NESFATIN 1; NEUROPEPTIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLUCOSE INTAKE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADMINISTRATION, ORAL; ADULT; APPETITE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; FOOD; GLUCOSE; HUMANS; HYPERPHAGIA; MALE; MIDDLE AGED; PEPTIDE HORMONES; SWEETENING AGENTS;

RODENTIA;

EID: 71349086261     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2009.11.003     Document Type: Article

References (19)

1. Oh I.S., Shimizu H., Satoh T., Okada S., Adachi S., Inoue K., Eguchi H., Yamamoto M., Imaki T., Hashimoto K., Tsuchiya T., Monden T., Horiguchi K., Yamada M., and Mori M. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 443 (2006) 709-712
2. Shimizu H., Oh I.S., Hashimoto K., Nakata M., Yamamoto S., Yoshida N., Eguchi H., Kato I., Inoue K., Satoh T., Okada S., Yamada M., Yada T., and Mori M. Peripheral administration of nesfatin-1 reduces food intake in mice: the leptin-independent mechanism. Endocrinology 150 (2009) 662-671
3. Brailoiu G.C., Dun S.L., Brailoiu E., Inan S., Yang J., Chang J.K., and Dun N.J. Nesfatin-1: distribution and interaction with a G protein-coupled receptor in the rat brain. Endocrinology 148 (2007) 5088-5094
4. Kohno D., Nakata M., Maejima Y., Shimizu H., Sedbazar U., Yoshida N., Dezaki K., Onaka T., Mori M., and Yada T. Nesfatin-1 neurons in paraventricular and supraoptic nuclei of the rat hypothalamus coexpress oxytocin and vasopressin and are activated by refeeding. Endocrinology 149 (2008) 1295-1301
5. Pan W., Hsuchou H., and Kastin A.J. Nesfatin-1 crosses the blood-brain barrier without saturation. Peptides 28 (2007) 2223-2228
6. Price T.O., Samson W.K., Niehoff M.L., and Banks W.A. Permeability of the blood-brain barrier to a novel satiety molecule nesfatin-1. Peptides 28 (2007) 2372-2381
7. Wiedmer P., Nogueiras R., Broglio F., D'Alessio D., and Tschop M.H. Ghrelin, obesity and diabetes. Nat Clin Pract Endocrinol Metab 3 (2007) 705-712
8. Stengel A., Goebel M., Yakubov I., Wang L., Witcher D., Coskun T., Tache Y., Sachs G., and Lambrecht N.W. Identification and characterization of nesfatin-1 immunoreactivity in endocrine cell types of the rat gastric oxyntic mucosa. Endocrinology 150 (2009) 232-238
9. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20 (1997) 1183-1197
10. Aydin S., Dag E., Ozkan Y., Erman F., Dagli A.F., Kilic N., Sahin I., Karatas F., Yoldas T., Barim A.O., and Kendir Y. Nesfatin-1 and ghrelin levels in serum and saliva of epileptic patients: hormonal changes can have a major effect on seizure disorders. Mol Cell Biochem 328 (2009) 49-56
11. Gonzalez R., Tiwari A., and Unniappan S. Pancreatic beta cells colocalize insulin and pronesfatin immunoreactivity in rodents. Biochem Biophys Res Commun 381 (2009) 643-648
12. Dong J., Peeters T.L., De Smet B., Moechars D., Delporte C., Vanden Berghe P., Coulie B., Tang M., and Depoortere I. Role of endogenous ghrelin in the hyperphagia of mice with streptozotocin-induced diabetes. Endocrinology 147 (2006) 2634-2642
13. Murdolo G., Lucidi P., Di Loreto C., Parlanti N., De Cicco A., Fatone C., Fanelli C.G., Bolli G.B., Santeusanio F., and De Feo P. Insulin is required for prandial ghrelin suppression in humans. Diabetes 52 (2003) 2923-2927
14. Reimer M.K., Pacini G., and Ahren B. Dose-dependent inhibition by ghrelin of insulin secretion in the mouse. Endocrinology 144 (2003) 916-921
15. Yoshimoto A., Mori K., Sugawara A., Mukoyama M., Yahata K., Suganami T., Takaya K., Hosoda H., Kojima M., Kangawa K., and Nakao K. Plasma ghrelin and desacyl ghrelin concentrations in renal failure. J Am Soc Nephrol 13 (2002) 2748-2752
16. Chen Y.D., Jeng C.Y., and Reaven G.M. HDL metabolism in diabetes. Diabetes Metab Rev 3 (1987) 653-668
17. Macro J.A., Dimaline R., and Dockray G.J. Identification and expression of prohormone-converting enzymes in the rat stomach. Am J Physiol 270 (1996) G87-G93
18. Xu L., Bloem B., Gaszner B., Roubos E.W., and Kozicz T. Sex-specific effects of fasting on urocortin 1, cocaine- and amphetamine-regulated transcript peptide and nesfatin-1 expression in the rat Edinger-Westphal nucleus. Neuroscience 162 (2009) 1141-1149
19. Stengel A., Goebel M., Wang L., Rivier J., Kobelt P., Monnikes H., Lambrecht N.W., and Tache Y. Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor. Endocrinology 150 (2009) 4911-4919